These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 17849791)

  • 1. [Effects of methimazole on the evolution of the allergic rhinitis of patients with Graves' disease].
    Valencia Zavala MP; Cortinas López L; Sánchez Olivas JA; Sánchez Olivas MA; Montes Montes J; Duarte Díaz RJ; León Oviedo C
    Rev Alerg Mex; 2007; 54(3):71-6. PubMed ID: 17849791
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Administration of thyroxine in treated Graves' disease. Effects on the level of antibodies to thyroid-stimulating hormone receptors and on the risk of recurrence of hyperthyroidism.
    Hashizume K; Ichikawa K; Sakurai A; Suzuki S; Takeda T; Kobayashi M; Miyamoto T; Arai M; Nagasawa T
    N Engl J Med; 1991 Apr; 324(14):947-53. PubMed ID: 1900575
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A 6-year follow-up of a randomized prospective trial comparing methimazole treatment with or without exogenous L-thyroxine in Chinese patients with Graves' disease.
    Liu X; Qiang W; Liu X; Liu L; Liu S; Gao A; Gao S; Shi B
    Exp Clin Endocrinol Diabetes; 2014 Nov; 122(10):564-7. PubMed ID: 25140995
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of thyroxine upon prevention of recurrence of Graves' disease treated with antithyroid drugs].
    Wu G; Jie Y; Situ Y
    Zhonghua Yi Xue Za Zhi; 2001 Mar; 81(5):274-5. PubMed ID: 11798886
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Remission of Graves' hyperthyroidism treated with methimazole.
    Bolaños F; González-Ortiz M; Durón H; Sánchez C
    Rev Invest Clin; 2002; 54(4):307-10. PubMed ID: 12415954
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of Graves' disease: effects of the administration of L-thyroxine associated with methimazole as a single daily dose.
    Perozim LM; Lima N; Knobel M; Cavaliere H; Medeiros-Neto G
    Eur J Med; 1993 Feb; 2(2):70-4. PubMed ID: 8258020
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Assessment of the clinical efficacy and safety of epinastine plus pseudoephedrine vs loratadine plus pseudoephedrine in perennial allergic rhinitis].
    Hernández Colín D; González Díaz SN; Rodríguez Medina R; Aguilar Angeles D; González Gámez J; Becerril Angeles M; Orea Solano M; Domínguez Henkel R; Segovia Ayala C
    Rev Alerg Mex; 2004; 51(1):23-8. PubMed ID: 15119752
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of single daily dose of methimazole and propylthiouracil in the treatment of Graves' hyperthyroidism.
    He CT; Hsieh AT; Pei D; Hung YJ; Wu LY; Yang TC; Lian WC; Huang WS; Kuo SW
    Clin Endocrinol (Oxf); 2004 Jun; 60(6):676-81. PubMed ID: 15163329
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcome of pediatric Graves' disease after treatment with antithyroid medication and radioiodine.
    Ward L; Huot C; Lambert R; Deal C; Collu R; Van Vliet G
    Clin Invest Med; 1999 Aug; 22(4):132-9. PubMed ID: 10497711
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Assessment of early immunosuppressive therapy in the prevention of complications of Graves' disease].
    Huszno B; Trofimiuk M; Gołkowski F; Plinta T; Szybiński Z
    Przegl Lek; 2004; 61(8):868-71. PubMed ID: 15789920
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of antihistamines after serious allergic reaction to methimazole in pediatric Graves' disease.
    Toderian AB; Lawson ML
    Pediatrics; 2014 May; 133(5):e1401-4. PubMed ID: 24777217
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Remission of Graves' disease is not related to early restoration of euthyroidism with high-dose methimazole therapy.
    Kruljac I; Solter D; Vrkljan AM; Solter M
    Endocr Res; 2015; 40(1):25-8. PubMed ID: 24833206
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antithyroid drug-induced immunomodulation in Graves' disease patients.
    Lechpammer M; Lukac J; Lechpammer S; Kusić Z
    Acta Med Croatica; 2002; 56(1):21-6. PubMed ID: 12455450
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sustained control of Graves' hyperthyroidism during long-term low-dose antithyroid drug therapy of patients with severe Graves' orbitopathy.
    Laurberg P; Berman DC; Andersen S; Bülow Pedersen I
    Thyroid; 2011 Sep; 21(9):951-6. PubMed ID: 21834677
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relation between therapy for hyperthyroidism and the course of Graves' ophthalmopathy.
    Bartalena L; Marcocci C; Bogazzi F; Manetti L; Tanda ML; Dell'Unto E; Bruno-Bossio G; Nardi M; Bartolomei MP; Lepri A; Rossi G; Martino E; Pinchera A
    N Engl J Med; 1998 Jan; 338(2):73-8. PubMed ID: 9420337
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes of serum cytokines in hyperthyroid Graves' disease patients at diagnosis and during methimazole treatment.
    Pedro AB; Romaldini JH; Takei K
    Neuroimmunomodulation; 2011; 18(1):45-51. PubMed ID: 20628263
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of circulating activated suppressor-like T cells by methimazole therapy for Graves' disease.
    Tötterman TH; Karlsson FA; Bengtsson M; Mendel-Hartvig I
    N Engl J Med; 1987 Jan; 316(1):15-22. PubMed ID: 2946953
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum levels of the interferon-gamma-inducible alpha chemokine CXCL10 in patients with active Graves' disease, and modulation by methimazole therapy and thyroidectomy.
    Antonelli A; Fallahi P; Rotondi M; Ferrari SM; Serio M; Miccoli P
    Br J Surg; 2006 Oct; 93(10):1226-31. PubMed ID: 16838393
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improvement of immunologic abnormalities associated with hyperthyroidism of Graves' disease during methimazole treatment.
    Murakami M; Koizumi Y; Aizawa T; Yamada T; Ishihara M; Hasegawa Y; Ogata H; Kamoi K; Kaneko K
    Horm Metab Res; 1988 Apr; 20(4):235-8. PubMed ID: 3397034
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of specific immunotherapy versus loratadine on serum adhesion molecules.
    Ferreira MB; Santos MC; Pregal AL; Alonso E; Santos AS; Palma-Carlos ML; Palma-Carlos AG
    Allerg Immunol (Paris); 2001 Oct; 33(8):319-22. PubMed ID: 11763722
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.